These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center. Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677 [TBL] [Abstract][Full Text] [Related]
8. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma. Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177 [TBL] [Abstract][Full Text] [Related]
9. Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma. Sohani AR; Jaffe ES; Harris NL; Ferry JA; Pittaluga S; Hasserjian RP Am J Surg Pathol; 2011 Nov; 35(11):1666-78. PubMed ID: 21997687 [TBL] [Abstract][Full Text] [Related]
10. Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma. Younes S; Subramanian A; Khan A; Zhao S; Binkley M; Natkunam Y Blood Cancer J; 2024 May; 14(1):92. PubMed ID: 38821935 [TBL] [Abstract][Full Text] [Related]
11. Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment? Fanale M Hematology Am Soc Hematol Educ Program; 2013; 2013():406-13. PubMed ID: 24319212 [TBL] [Abstract][Full Text] [Related]
12. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas. Tian X; Xu J; Dorfman DM Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma. Visser L; Rutgers B; Diepstra A; van den Berg A; Sattarzadeh A Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999289 [TBL] [Abstract][Full Text] [Related]
15. Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Review of Current Literature and Case Discussion. Sidda A; Naleid NK; Manu G; Graffeo V; Jamil MO J Investig Med High Impact Case Rep; 2022; 10():23247096221111767. PubMed ID: 35861500 [TBL] [Abstract][Full Text] [Related]
16. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma. Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733 [TBL] [Abstract][Full Text] [Related]
17. EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults. Huppmann AR; Nicolae A; Slack GW; Pittaluga S; Davies-Hill T; Ferry JA; Harris NL; Jaffe ES; Hasserjian RP Am J Surg Pathol; 2014 Mar; 38(3):316-24. PubMed ID: 24525501 [TBL] [Abstract][Full Text] [Related]
18. Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma? Barber NA; Loberiza FR; Perry AM; Bast M; Holdeman KP; Esfahane AB; Weisenburger DD; Vose J; Bierman P; Armitage JO; Bociek RG Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):392-7. PubMed ID: 23773450 [TBL] [Abstract][Full Text] [Related]